Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Migraine

  Free Subscription


Articles published in Headache

Retrieve available abstracts of 420 articles:
HTML format



Single Articles


    August 2020
  1. CAPE S
    Access to Migraine Treatments in Ontario, Canada: A Review of the Ontario Drug Benefit Program.
    Headache. 2020 Aug 5. doi: 10.1111/head.13918.
    PubMed     Abstract available


  2. PEARL TA, Dumkrieger G, Chong CD, Dodick DW, et al
    Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR).
    Headache. 2020 Aug 4. doi: 10.1111/head.13911.
    PubMed     Abstract available


  3. SPECK RM, Collins EM, Lombard L, Ayer DW, et al
    A Qualitative Study to Assess the Content Validity of the 24-Hour Migraine Quality of Life Questionnaire in Patients with Migraine.
    Headache. 2020 Aug 3. doi: 10.1111/head.13915.
    PubMed     Abstract available


  4. ROGERS DG, Bond DS, Bentley JP, Smitherman TA, et al
    Objectively Measured Physical Activity in Migraine as a Function of Headache Activity.
    Headache. 2020 Aug 2. doi: 10.1111/head.13921.
    PubMed     Abstract available


    July 2020
  5. WATTIEZ AS, O'Shea SA, Ten Eyck P, Sowers LP, et al
    Patients With Vestibular Migraine are More Likely to Have Occipital Headaches than those With Migraine Without Vestibular Symptoms.
    Headache. 2020 Jul 25. doi: 10.1111/head.13898.
    PubMed     Abstract available


  6. FORBES RB, McCarron M, Cardwell CR
    Efficacy and Contextual (Placebo) Effects of CGRP Antibodies for Migraine: Systematic Review and Meta-analysis.
    Headache. 2020 Jul 15. doi: 10.1111/head.13907.
    PubMed     Abstract available


  7. CAROLI A, Klan T, Gaul C, Kubik SU, et al
    Types of Triggers in Migraine - Factor Structure of the Headache Triggers Sensitivity and Avoidance Questionnaire and Development of a New Short Form (HTSAQ-SF).
    Headache. 2020 Jul 11. doi: 10.1111/head.13896.
    PubMed     Abstract available


  8. TEPPER SJ, Vasudeva R, Krege JH, Rathmann SS, et al
    Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.
    Headache. 2020 Jul 7. doi: 10.1111/head.13897.
    PubMed     Abstract available


  9. LIAMPAS I, Siokas V, Mentis AA, Aloizou AM, et al
    Serum Homocysteine, Pyridoxine, Folate, and Vitamin B12 Levels in Migraine: Systematic Review and Meta-Analysis.
    Headache. 2020 Jul 2. doi: 10.1111/head.13892.
    PubMed     Abstract available


    June 2020
  10. BURSTEIN R, Blumenfeld AM, Silberstein SD, Manack Adams A, et al
    Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.
    Headache. 2020 Jun 30. doi: 10.1111/head.13849.
    PubMed     Abstract available


  11. DANNO D, Wolf J, Ishizaki K, Kikui S, et al
    Cranial Autonomic Symptoms of Migraine in Japan: Prospective Study of 373 Migraine Patients at a Tertiary Headache Center.
    Headache. 2020 Jun 27. doi: 10.1111/head.13888.
    PubMed     Abstract available


  12. JAKATE A, Boinpally R, Butler M, Lu K, et al
    Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans.
    Headache. 2020 Jun 23. doi: 10.1111/head.13862.
    PubMed     Abstract available


  13. KARSAN N, Bose PR, O'Daly O, Zelaya FO, et al
    Alterations in Functional Connectivity During Different Phases of the Triggered Migraine Attack.
    Headache. 2020 Jun 22. doi: 10.1111/head.13865.
    PubMed     Abstract available


  14. RUSSO A, Silvestro M, Trojsi F, Bisecco A, et al
    Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia.
    Headache. 2020 Jun 13. doi: 10.1111/head.13860.
    PubMed     Abstract available


  15. PORTA-ETESSAM J, Gonzalez-Garcia N, Matias-Guiu JA, Montero-Escribano P, et al
    Should we adapt the prescription criteria for specific treatments for migraine due to the Covid-19 pandemic?
    Headache. 2020 Jun 11. doi: 10.1111/head.13880.
    PubMed     Abstract available


  16. SINGH J, Ali A
    Headache as the Presenting Symptom in 2 Patients with COVID-19 and a History of Migraine: 2 Case Reports.
    Headache. 2020 Jun 10. doi: 10.1111/head.13890.
    PubMed     Abstract available


  17. CHAN TLH, Cowan RP, Woldeamanuel YW
    Calcitonin Gene-Related Peptide Receptor Antagonists (Gepants) for the Acute Treatment of Nausea in Episodic Migraine: A Systematic Review and Meta-Analysis.
    Headache. 2020 Jun 9. doi: 10.1111/head.13858.
    PubMed     Abstract available


  18. LOMBARD L, Ye W, Nichols R, Jackson J, et al
    A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment.
    Headache. 2020 Jun 8. doi: 10.1111/head.13835.
    PubMed     Abstract available


  19. ROBBINS L, Tropp-Bluestone M
    Evolution and Migraine.
    Headache. 2020 Jun 8. doi: 10.1111/head.13837.
    PubMed    


  20. PEREZ-PEREDA S, Gonzalez-Quintanilla V, Madera J, Pascual J, et al
    Chronic Migraine With Apparent Loss of Response to Onabotulinum Toxin Type A Due to Local Nitroglycerin Treatment for an Anal Fissure: A Case Report.
    Headache. 2020 Jun 3. doi: 10.1111/head.13863.
    PubMed     Abstract available


  21. KEARNEY E, Collins T, Sengupta S
    De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm.
    Headache. 2020 Jun 1. doi: 10.1111/head.13855.
    PubMed    


  22. TEPPER D
    Lasmiditan for the acute treatment of migraine.
    Headache. 2020;60:1225-1226.
    PubMed    


  23. VIGANO A, Mancini V, Mastria G, Di Piero V, et al
    Is it Useful to Do a Taxonomy of Complex Visual Symptoms in Migraine? A Comment on Coining the Pablo Picasso Syndrome.
    Headache. 2020;60:1200-1201.
    PubMed    


  24. ALI A
    Delay in OnabotulinumtoxinA Treatment During the COVID-19 Pandemic-Perspectives from a Virus Hotspot.
    Headache. 2020;60:1183-1186.
    PubMed     Abstract available


    May 2020
  25. RUSSO A, Lavorgna L, Silvestro M, Abbadessa G, et al
    Readability Analysis of Online Headache and Migraine Information.
    Headache. 2020 May 28. doi: 10.1111/head.13818.
    PubMed     Abstract available


  26. GVANTSELADZE K, Do TP, Hansen JM, Shapiro RE, et al
    The Stereotypical Image of a Person With Migraine According to Mass Media.
    Headache. 2020 May 27. doi: 10.1111/head.13846.
    PubMed     Abstract available


  27. HINDIYEH NA, Zhang N, Farrar M, Banerjee P, et al
    The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review.
    Headache. 2020 May 25. doi: 10.1111/head.13836.
    PubMed     Abstract available


  28. PELLESI L, Do TP, Ashina H, Ashina M, et al
    Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
    Headache. 2020 May 21. doi: 10.1111/head.13843.
    PubMed     Abstract available


  29. GIBBS SN, Shah S, Deshpande CG, Bensink ME, et al
    United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
    Headache. 2020 May 5. doi: 10.1111/head.13829.
    PubMed     Abstract available


  30. SILVESTRO M, Tessitore A, Scotto di Clemente F, Tedeschi G, et al
    Erenumab Efficacy on Comorbid Cluster Headache in Patients With Migraine: A Real-World Case Series.
    Headache. 2020 May 2. doi: 10.1111/head.13832.
    PubMed     Abstract available


  31. WELLS RE, Strauss LD
    The Value of Headache-Specific Recommendations During COVID-19.
    Headache. 2020;60:820-823.
    PubMed    


  32. EGHTESADI M, Marquis-Gravel G
    Rethinking Our Cardiovascular Risk Assessment in the Younger Female Migraine Population.
    Headache. 2020;60:994-997.
    PubMed    


    April 2020
  33. LIAMPAS I, Siokas V, Brotis A, Vikelis M, et al
    Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis.
    Headache. 2020 Apr 30. doi: 10.1111/head.13828.
    PubMed     Abstract available


  34. GRAZZI L, Rizzoli P
    The Adaptation of Management of Chronic Migraine Patients With Medication Overuse to the Suspension of Treatment Protocols During the COVID-19 Pandemic: Lessons From a Tertiary Headache Center in Milan, Italy.
    Headache. 2020 Apr 30. doi: 10.1111/head.13825.
    PubMed    


  35. BEGASSE DE DHAEM O, Gharedaghi MH, Rizzoli P
    Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice.
    Headache. 2020 Apr 25. doi: 10.1111/head.13823.
    PubMed     Abstract available


  36. NAHMAN-AVERBUCH H, Schneider VJ 2nd, Chamberlin LA, Kroon Van Diest AM, et al
    Alterations in Brain Function After Cognitive Behavioral Therapy for Migraine in Children and Adolescents.
    Headache. 2020 Apr 23. doi: 10.1111/head.13814.
    PubMed     Abstract available


  37. HAMMOND NG, Colman I
    The Role of Positive Health Behaviors in the Relationship Between Early Life Stress and Migraine.
    Headache. 2020 Apr 22. doi: 10.1111/head.13808.
    PubMed     Abstract available


  38. HOMMEL KA, Carmody J, Hershey AD, Holbein C, et al
    Digital Therapeutic Self-Management Intervention in Adolescents With Migraine: Feasibility and Preliminary Efficacy of "Migraine Manager".
    Headache. 2020 Apr 22. doi: 10.1111/head.13805.
    PubMed     Abstract available


  39. ALBANES OLIVEIRA BERNARDO A, Lys Medeiros F, Sampaio Rocha-Filho PA
    Osmophobia and Odor-Triggered Headaches in Children and Adolescents: Prevalence, Associated Factors, and Importance in the Diagnosis of Migraine.
    Headache. 2020 Apr 15. doi: 10.1111/head.13806.
    PubMed     Abstract available


  40. CELIKBILEK A
    Inflammatory Milieu May Trigger Metabolic Changes in Migraine Attacks.
    Headache. 2020 Apr 15. doi: 10.1111/head.13799.
    PubMed    


  41. FREDERIKSEN SD, Bekker-Nielsen Dunbar M, Snoer AH, Deen M, et al
    Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
    Headache. 2020 Apr 15. doi: 10.1111/head.13802.
    PubMed     Abstract available


  42. VIEIRA A, van der Linde I, Bright P, Wilkins A, et al
    Preference for Lighting Chromaticity in Migraine With Aura.
    Headache. 2020 Apr 13. doi: 10.1111/head.13801.
    PubMed     Abstract available


  43. SILVESTRO M, Tessitore A, Tedeschi G, Russo A, et al
    Migraine in the Time of COVID-19.
    Headache. 2020 Apr 8. doi: 10.1111/head.13803.
    PubMed    


  44. MINEN MT, Robbins MS, Loder E, Nahas S, et al
    Addressing the Crisis of Diagnosis and Management of Migraine in Primary Care: A Summary of the American Headache Society FrontLine Primary Care Advisory Board.
    Headache. 2020 Apr 8. doi: 10.1111/head.13797.
    PubMed    


  45. TIETJEN GE, Maly EF
    Migraine and Ischemic Stroke in Women. A Narrative Review.
    Headache. 2020 Apr 4. doi: 10.1111/head.13796.
    PubMed     Abstract available


    March 2020
  46. FERNANDES L, Khan N, Dobson J, Randall M, et al
    Multiple Cranial Nerve Blocks as an Alternative Preventative Therapy for Chronic Migraine.
    Headache. 2020 Mar 30. doi: 10.1111/head.13792.
    PubMed     Abstract available


  47. SZPERKA CL, Ailani J, Barmherzig R, Klein BC, et al
    Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.
    Headache. 2020 Mar 30. doi: 10.1111/head.13810.
    PubMed     Abstract available


  48. MINEN MT, Jalloh A, Begasse de Dhaem O, Seng EK, et al
    Behavioral Therapy Preferences in People With Migraine.
    Headache. 2020 Mar 23. doi: 10.1111/head.13790.
    PubMed     Abstract available


  49. MAKAR GS, Siegal T, Syrow L
    Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome: A Rare, Reversible Complication of Radiation Therapy.
    Headache. 2020 Mar 23. doi: 10.1111/head.13786.
    PubMed    


  50. GEORGE KM, Folsom AR, Sharrett AR, Mosley TH, et al
    Migraine Headache and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study.
    Headache. 2020 Mar 22. doi: 10.1111/head.13794.
    PubMed     Abstract available


  51. RODRIGUEZ-CASTRO E, Lagorio AN, Bejarano-Garcia A, Aguiar P, et al
    Prolonged Migraine Stuttering Aura: Structural, Functional, and Video Neuroimaging Study of an Atypical Migraine Aura. A Case Report.
    Headache. 2020 Mar 5. doi: 10.1111/head.13780.
    PubMed     Abstract available


    February 2020
  52. CRAWFORD MR, Luik AI, Espie CA, Taylor HL, et al
    Digital Cognitive Behavioral Therapy for Insomnia in Women With Chronic Migraines.
    Headache. 2020 Feb 28. doi: 10.1111/head.13777.
    PubMed     Abstract available


  53. FALLA K, Ronksley P, Noel M, Orr SL, et al
    Internalizing Symptoms in Pediatric Migraine: A Systematic Review Protocol.
    Headache. 2020 Feb 25. doi: 10.1111/head.13778.
    PubMed     Abstract available


  54. GRAZZI L, Rizzoli P
    Acceptance and Commitment Therapy (ACT) vs Erenumab for High Frequency Episodic Migraine Without Aura: Time to Take the Gloves Off!
    Headache. 2020 Feb 25. doi: 10.1111/head.13776.
    PubMed    


  55. ORNELLO R, Frattale I, Pistoia F, Sacco S, et al
    Erenumab Plus Subcutaneous Immunoglobulin in a Patient With Comorbid Chronic Migraine and Myasthenia Gravis.
    Headache. 2020 Feb 25. doi: 10.1111/head.13779.
    PubMed    


  56. DODICK DW, Lipton RB, Ailani J, Halker Singh RB, et al
    Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.
    Headache. 2020 Feb 19. doi: 10.1111/head.13766.
    PubMed     Abstract available


  57. CARONNA E, Gallardo VJ, Fonseca E, Gomez-Galvan JB, et al
    How Does Migraine Change After 10 Years? A Clinical Cohort Follow-Up Analysis.
    Headache. 2020 Feb 18. doi: 10.1111/head.13774.
    PubMed     Abstract available


  58. GOLLION C, Arribarat G, Ruidavets JB, Fabre N, et al
    Neuromelanin Locus Coeruleus MRI Contrast in Migraine With Aura.
    Headache. 2020 Feb 17. doi: 10.1111/head.13771.
    PubMed     Abstract available


  59. STUBBERUD A, Tronvik E, Olsen A, Gravdahl G, et al
    Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study.
    Headache. 2020 Feb 13. doi: 10.1111/head.13772.
    PubMed     Abstract available


  60. LEWIS R, Ruiz A, Monteith T
    Reversible Lesion of the Corpus Callosum in a Patient With Migraine With Aura: A Case Study.
    Headache. 2020 Feb 11. doi: 10.1111/head.13768.
    PubMed     Abstract available


  61. WINNER PK, Kabbouche M, Yonker M, Wangsadipura V, et al
    A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine.
    Headache. 2020 Feb 9. doi: 10.1111/head.13754.
    PubMed     Abstract available


  62. ORR SL, Turner A, Kabbouche MA, Horn PS, et al
    The Profile and Prognosis of Youth With Status Migrainosus: Results From an Observational Study.
    Headache. 2020 Feb 7. doi: 10.1111/head.13767.
    PubMed     Abstract available


  63. ZHANG DG, Amin FM, Guo S, Vestergaard MB, et al
    Plasma Glucose Levels Increase During Spontaneous Attacks of Migraine With and Without Aura.
    Headache. 2020 Feb 7. doi: 10.1111/head.13760.
    PubMed     Abstract available


  64. LEE YH, Huang IH, Kang YN
    Do Treatment Strategies of Fremanezumab Have Similar Effect on Migraine?
    Headache. 2020;60:473-475.
    PubMed    


    January 2020
  65. HOUGAARD A, Younis S, Iljazi A, Sugimoto K, et al
    Intravenous Endothelin-1 Infusion Does Not Induce Aura or Headache in Migraine Patients With Aura.
    Headache. 2020 Jan 29. doi: 10.1111/head.13753.
    PubMed     Abstract available


  66. RIGGINS N, Ehrlich A, Sawhney H, Dapkus L, et al
    Retrospective Chart Review of Intravenous Valproate Sodium as a Preventive Treatment for Patients With Chronic Migraine.
    Headache. 2020 Jan 27. doi: 10.1111/head.13756.
    PubMed     Abstract available


  67. PURDY RA
    Migraine and Other Primary Headaches.
    Headache. 2020 Jan 26. doi: 10.1111/head.13750.
    PubMed    


  68. MINEN MT, Sahyoun G, Gopal A, Levitan V, et al
    A Pilot Randomized Controlled Trial to Assess the Impact of Motivational Interviewing on Initiating Behavioral Therapy for Migraine.
    Headache. 2020 Jan 24. doi: 10.1111/head.13738.
    PubMed     Abstract available


  69. DIENER HC
    The Risks or Lack Thereof of Migraine Treatments in Vascular Disease.
    Headache. 2020 Jan 22. doi: 10.1111/head.13749.
    PubMed     Abstract available


  70. CHONG CD, Aguilar M, Schwedt TJ
    Altered Hypothalamic Region Covariance in Migraine and Cluster Headache: A Structural MRI Study.
    Headache. 2020 Jan 22. doi: 10.1111/head.13742.
    PubMed     Abstract available


  71. SPROUSE BLUM AS, Couperus CJ, Rosen BJ, Haskin-Leahy LF, et al
    Familial "Diplegic" Migraine - Description of a Family With a Novel CACNA1A Mutation.
    Headache. 2020 Jan 22. doi: 10.1111/head.13741.
    PubMed     Abstract available


  72. PEARL TA, Dumkrieger G, Chong CD, Dodick DW, et al
    Sensory Hypersensitivity Symptoms in Migraine With vs Without Aura: Results From the American Registry for Migraine Research.
    Headache. 2020 Jan 22. doi: 10.1111/head.13745.
    PubMed     Abstract available


  73. FALKENBERG K, Ronde Bjerg H, Yamani N, Olesen J, et al
    Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.
    Headache. 2020 Jan 16. doi: 10.1111/head.13747.
    PubMed     Abstract available


  74. D'AMICO D, Grazzi L, Grignani E, Leonardi M, et al
    HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine?
    Headache. 2020 Jan 13. doi: 10.1111/head.13735.
    PubMed     Abstract available


  75. DARSEY M, Kyros T, Wang V, Rizzoli PB, et al
    Intranasal 3% Tetracaine Plus 0.05% Oxymetazoline in the Management of Status Migrainosus.
    Headache. 2020 Jan 9. doi: 10.1111/head.13739.
    PubMed    


  76. SCOTT BR, Uomoto JM, Barry ES
    Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion.
    Headache. 2020 Jan 3. doi: 10.1111/head.13709.
    PubMed     Abstract available


  77. AILANI J, Lipton RB, Hutchinson S, Knievel K, et al
    Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial.
    Headache. 2020;60:141-152.
    PubMed     Abstract available


  78. NYE B, Thadani V
    Migraine and Driving.
    Headache. 2020;60:13-14.
    PubMed    


  79. RAPOPORT AM, Lin T, Tepper SJ
    Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine.
    Headache. 2020;60:229-234.
    PubMed     Abstract available


    December 2019
  80. EVANS RW, Burch RC, Frishberg BM, Marmura MJ, et al
    Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline.
    Headache. 2019 Dec 31. doi: 10.1111/head.13720.
    PubMed     Abstract available


  81. RICHMOND L, Schneider RP, Steffel J, Sandor PS, et al
    Case Report: New-Onset Retinal Migraine After Transseptal Catheterization.
    Headache. 2019 Dec 30. doi: 10.1111/head.13732.
    PubMed     Abstract available


  82. SPROUSE BLUM AS, Lavoie B, Haag M, Mawe SM, et al
    No Gastrointestinal Dysmotility in Transgenic Mouse Models of Migraine.
    Headache. 2019 Dec 26. doi: 10.1111/head.13724.
    PubMed     Abstract available


  83. ZHANG N, Houle T, Hindiyeh N, Aurora SK, et al
    Systematic Review: Acupuncture vs Standard Pharmacological Therapy for Migraine Prevention.
    Headache. 2019 Dec 24. doi: 10.1111/head.13723.
    PubMed     Abstract available


  84. MUNJAL S, Singh P, Reed ML, Fanning K, et al
    Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
    Headache. 2019 Dec 14. doi: 10.1111/head.13708.
    PubMed     Abstract available


  85. HOUTS CR, Wirth RJ, McGinley JS, Gwaltney C, et al
    Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative Review.
    Headache. 2019 Dec 6. doi: 10.1111/head.13701.
    PubMed     Abstract available


  86. MINEN MT, Zhou K, Miller L
    A Brief Look at Urgent Care Visits for Migraine: The Care Received and Ideas to Guide Migraine Care in this Proliferating Medical Setting.
    Headache. 2019 Dec 4. doi: 10.1111/head.13717.
    PubMed     Abstract available


  87. TEPPER SJ, Silberstein SD, Rosen NL, Lipton RB, et al
    The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings.
    Headache. 2019 Dec 2. doi: 10.1111/head.13716.
    PubMed     Abstract available


    November 2019
  88. MANSOUR AG, Ahdab R, Daaboul Y, Korjian S, et al
    Vitamin K2 Status and Arterial Stiffness Among Untreated Migraine Patients: A Case-Control Study.
    Headache. 2019 Nov 25. doi: 10.1111/head.13715.
    PubMed     Abstract available


  89. SCHWEDT TJ, Digre K, Tepper SJ, Spare NM, et al
    The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
    Headache. 2019 Nov 22. doi: 10.1111/head.13688.
    PubMed     Abstract available


  90. HORNIK CP, Gelfand AA, Szperka CL, Pezzuto T, et al
    Development of a Prospective Real-World Data Clinical Registry of Children and Adolescents With Migraine.
    Headache. 2019 Nov 22. doi: 10.1111/head.13714.
    PubMed     Abstract available


  91. KHAN FA, Mohammed AE, Poongkunran M, Chimakurthy A, et al
    Wearing Off Effect of OnabotulinumtoxinA Near the End of Treatment Cycle for Chronic Migraine: A 4-Year Clinical Experience.
    Headache. 2019 Nov 22. doi: 10.1111/head.13713.
    PubMed     Abstract available


  92. OAKES TM, Kovacs R, Rosen N, Doty E, et al
    Evaluation of Cardiovascular Outcomes in Adult Patients With Episodic or Chronic Migraine Treated With Galcanezumab: Data From Three Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1, EVOLVE-2, and REGAIN Studies.
    Headache. 2019 Nov 13. doi: 10.1111/head.13684.
    PubMed     Abstract available


  93. YOM KH, Ricca AM, Ko AC
    Orbital Mass in a Patient With Exacerbation of Chronic Migraine - A Case Report.
    Headache. 2019 Nov 13. doi: 10.1111/head.13698.
    PubMed    


  94. DETKE HC, Millen BA, Zhang Q, Samaan K, et al
    Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies.
    Headache. 2019 Nov 11. doi: 10.1111/head.13691.
    PubMed     Abstract available


  95. WANG R, Nie X, Xu S, Zhang M, et al
    Interrelated Pathogenesis? Neuronal Intranuclear Inclusion Disease Combining With Hemiplegic Migraine.
    Headache. 2019 Nov 8. doi: 10.1111/head.13687.
    PubMed     Abstract available


  96. GONZALEZ-MARTINEZ A, Rodriguez Vazquez E, de la Red Gallego H, Garcia-Azorin D, et al
    Association Between Personality Traits and Onabotulinumtoxin A Response in Patients With Chronic Migraine.
    Headache. 2019 Nov 6. doi: 10.1111/head.13693.
    PubMed     Abstract available


  97. CHIARUGI A
    A Popperian View on Anti-CGRP Biologics in Migraine.
    Headache. 2019 Nov 6. doi: 10.1111/head.13695.
    PubMed    


  98. MICHELS L, Villanueva J, O'Gorman R, Muthuraman M, et al
    Interictal Hyperperfusion in the Higher Visual Cortex in Patients With Episodic Migraine.
    Headache. 2019 Nov 4. doi: 10.1111/head.13646.
    PubMed     Abstract available


  99. WINNER PK, Spierings ELH, Yeung PP, Aycardi E, et al
    Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.
    Headache. 2019 Nov 1. doi: 10.1111/head.13654.
    PubMed     Abstract available


  100. TURNER SB, Rende EK, Szperka CL, Hershey AD, et al
    The Development of the Pediatric Migraine Action Plan (PedMAP).
    Headache. 2019;59:1671-1672.
    PubMed    


  101. TURNER SB, Rende EK, Pezzuto T, Weaver S, et al
    Pediatric Migraine Action Plan (PedMAP).
    Headache. 2019;59:1871-1873.
    PubMed    


  102. LODER EW, Tfelt-Hansen P
    Further Questioning of the Significance of the Gepants: A Response.
    Headache. 2019;59:1831.
    PubMed    


  103. NGUYEN J, Hu D
    Further Questioning of the Significance of the Gepants.
    Headache. 2019;59:1829-1830.
    PubMed    


    October 2019
  104. LIPTON RB, Munjal S, Brand-Schieber E, Tepper SJ, et al
    Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
    Headache. 2019 Oct 24. doi: 10.1111/head.13663.
    PubMed     Abstract available


  105. MELHADO EM, Thiers Rister HL, Galego DR, de Oliveira AB, et al
    Allodynia in Menstrually Related Migraine: Score Assessment by Allodynia Symptom Checklist (ASC-12).
    Headache. 2019 Oct 21. doi: 10.1111/head.13677.
    PubMed     Abstract available


  106. CONNELLY M, Sekhon S, Stephens D, Boorigie M, et al
    Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol ("CAMP").
    Headache. 2019 Oct 18. doi: 10.1111/head.13685.
    PubMed     Abstract available


  107. SAKAI F, Takeshima T, Tatsuoka Y, Hirata K, et al
    A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.
    Headache. 2019 Oct 14. doi: 10.1111/head.13652.
    PubMed     Abstract available


  108. CHEN SP, Eikermann-Haerter K
    How Imaging Can Help Us Better Understand the Migraine-Stroke Connection.
    Headache. 2019 Oct 3. doi: 10.1111/head.13664.
    PubMed     Abstract available


  109. BURCH R
    Epidemiology and Treatment of Menstrual Migraine and Migraine During Pregnancy and Lactation: A Narrative Review.
    Headache. 2019 Oct 3. doi: 10.1111/head.13665.
    PubMed     Abstract available


  110. SLAVIN M, Li HA, Frankenfeld C, Cheskin LJ, et al
    What is Needed for Evidence-Based Dietary Recommendations for Migraine: A Call to Action for Nutrition and Microbiome Research.
    Headache. 2019;59:1566-1581.
    PubMed     Abstract available


  111. CHUA AL, Grosberg BM, Evans RW
    Status Migrainosus in Children and Adults.
    Headache. 2019;59:1611-1623.
    PubMed    


    September 2019
  112. LEROUX E, Rothrock J
    Triptans for Migraine Patients With Vascular Risks: New Insights, New Options.
    Headache. 2019 Sep 30. doi: 10.1111/head.13656.
    PubMed    


  113. SENG EK, Singer AB, Metts C, Grinberg AS, et al
    Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.
    Headache. 2019 Sep 26. doi: 10.1111/head.13657.
    PubMed     Abstract available


  114. GUTTA R, Valentini KJ, Kaur G, Farooqi AA, et al
    Management of Childhood Migraine by Headache Specialist vs Non-Headache Specialists.
    Headache. 2019 Sep 26. doi: 10.1111/head.13660.
    PubMed     Abstract available


  115. OZUDOGRU S, Neufeld A, Katz BJ, Baggaley S, et al
    Reduced Visual Quality of Life Associated with Migraine is Most Closely Correlated with Symptoms of Dry Eye.
    Headache. 2019 Sep 26. doi: 10.1111/head.13662.
    PubMed     Abstract available


  116. LEE HH, Chen CC, Ong JR, Lin YF, et al
    Association of rs2651899 Polymorphism in the Positive Regulatory Domain 16 and Common Migraine Subtypes: A Meta-Analysis.
    Headache. 2019 Sep 26. doi: 10.1111/head.13670.
    PubMed     Abstract available


  117. CERIANI CEJ, Wilhour DA, Silberstein SD
    Novel Medications for the Treatment of Migraine.
    Headache. 2019 Sep 26. doi: 10.1111/head.13661.
    PubMed     Abstract available


  118. ROTA E, Zucco R, Guerzoni S, Cainazzo MM, et al
    Migraine Awareness in Italy and the Myth of "Cervical Arthrosis".
    Headache. 2019 Sep 26. doi: 10.1111/head.13679.
    PubMed     Abstract available


  119. KNOL MJ, Loehrer EA, Wen KX, Bos D, et al
    Migraine Genetic Variants Influence Cerebral Blood Flow.
    Headache. 2019 Sep 26. doi: 10.1111/head.13651.
    PubMed     Abstract available


  120. ROTHROCK JF, Adams AM, Lipton RB, Silberstein SD, et al
    FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
    Headache. 2019 Sep 26. doi: 10.1111/head.13653.
    PubMed     Abstract available


  121. LIPTON RB, Hutchinson S, Ailani J, Reed ML, et al
    Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Headache. 2019 Sep 22. doi: 10.1111/head.13642.
    PubMed     Abstract available


  122. RAVN J, Chalmer MA, Oehrstroem EL, Kogelman LJA, et al
    Characterization of Familial and Sporadic Migraine.
    Headache. 2019 Sep 22. doi: 10.1111/head.13640.
    PubMed     Abstract available


  123. MANCINI AJ, Glassman RD, Chang YM, Burstein R, et al
    Headache in Petrous Apicitis: A Case Report of Chronic Migraine-like Headache Due to Peripheral Pathology.
    Headache. 2019 Sep 18. doi: 10.1111/head.13643.
    PubMed     Abstract available


  124. FENG Y, Zhang B, Zhang J, Yin Y, et al
    Effects of Non-invasive Brain Stimulation on Headache Intensity and Frequency of Headache Attacks in Patients With Migraine: A Systematic Review and Meta-Analysis.
    Headache. 2019 Sep 18. doi: 10.1111/head.13645.
    PubMed     Abstract available


  125. ASHINA M, Vasudeva R, Jin L, Lombard L, et al
    Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies.
    Headache. 2019 Sep 17. doi: 10.1111/head.13636.
    PubMed     Abstract available


  126. MASTERS-ISRAILOV A, Robbins MS
    OnabotulinumtoxinA Wear-off Phenomenon in the Treatment of Chronic Migraine.
    Headache. 2019 Sep 16. doi: 10.1111/head.13638.
    PubMed     Abstract available


  127. HAMMOND NG, Orr SL, Colman I
    Early Life Stress in Adolescent Migraine and the Mediational Influence of Symptoms of Depression and Anxiety in a Canadian Cohort.
    Headache. 2019 Sep 16. doi: 10.1111/head.13644.
    PubMed     Abstract available


  128. BARBANTI P, Egeo G, Mitsikostas DD
    Trigeminal-Targeted Treatments in Migraine: Is 60% the Magic Number?
    Headache. 2019 Sep 11. doi: 10.1111/head.13635.
    PubMed     Abstract available


  129. VANDERPLUYM JH, Hamilton K, Hindiyeh NA, Robbins MS, et al
    Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program.
    Headache. 2019 Sep 11. doi: 10.1111/head.13649.
    PubMed    


  130. CHING J, Tinsley A, Rothrock J
    Prognosis Following Discontinuation of OnabotulinumA Therapy in "Super-responding" Chronic Migraine Patients.
    Headache. 2019 Sep 9. doi: 10.1111/head.13630.
    PubMed     Abstract available


  131. OSKOUI M, Pringsheim T, Holler-Managan Y, Potrebic S, et al
    Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Headache. 2019;59:1158-1173.
    PubMed     Abstract available


  132. OSKOUI M, Pringsheim T, Billinghurst L, Potrebic S, et al
    Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Headache. 2019;59:1144-1157.
    PubMed     Abstract available


    August 2019
  133. TOGHA M, Razeghi Jahromi S, Ghorbani Z, Martami F, et al
    Serum Vitamin B12 and Methylmalonic Acid Status in Migraineurs: A Case-Control Study.
    Headache. 2019 Aug 31. doi: 10.1111/head.13618.
    PubMed     Abstract available


  134. SANDOE CH, Sasikumar S, Lay C, Lawler V, et al
    The Impact of Shift Work on Migraine: A Case Series and Narrative Review.
    Headache. 2019 Aug 30. doi: 10.1111/head.13622.
    PubMed     Abstract available


  135. BUCH D, Chabriat H
    Lamotrigine in the Prevention of Migraine With Aura: A Narrative Review.
    Headache. 2019 Aug 29. doi: 10.1111/head.13615.
    PubMed     Abstract available


  136. VERNIERI F, Paolucci M, Altamura C, Pasqualetti P, et al
    Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience.
    Headache. 2019 Aug 27. doi: 10.1111/head.13617.
    PubMed     Abstract available


  137. HAIGH SM, Chamanzar A, Grover P, Behrmann M, et al
    Cortical Hyper-Excitability in Migraine in Response to Chromatic Patterns.
    Headache. 2019 Aug 27. doi: 10.1111/head.13620.
    PubMed     Abstract available


  138. HAJJARZADEH S, Nikniaz Z, Shalilahmadi D, Mahdavi R, et al
    Comparison of Diet Quality Between Women With Chronic and Episodic Migraine.
    Headache. 2019 Aug 27. doi: 10.1111/head.13623.
    PubMed     Abstract available


  139. LIPTON RB, Munjal S, Buse DC, Alam A, et al
    Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
    Headache. 2019 Aug 13. doi: 10.1111/head.13588.
    PubMed     Abstract available


  140. BUSE DC, Fanning KM, Reed ML, Murray S, et al
    Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Headache. 2019 Aug 12. doi: 10.1111/head.13613.
    PubMed     Abstract available


  141. HAMMOND NG, Stinchcombe A
    Health Behaviors and Social Determinants of Migraine in a Canadian Population-Based Sample of Adults Aged 45-85 Years: Findings From the CLSA.
    Headache. 2019 Aug 2. doi: 10.1111/head.13610.
    PubMed     Abstract available


    July 2019
  142. MCCLAIN IJ, Tsai MA, Guardia CF 3rd
    Prolonged Postictal Coma in Hemiplegic Migraine: A Case Report.
    Headache. 2019 Jul 24. doi: 10.1111/head.13606.
    PubMed    


  143. BORKUM JM
    CGRP and Brain Functioning: Cautions for Migraine Treatment.
    Headache. 2019 Jul 21. doi: 10.1111/head.13591.
    PubMed     Abstract available


  144. MATHEW PG, Klein BC
    Getting to the Heart of the Matter: Migraine, Triptans, DHE, Ditans, CGRP Antibodies, First/Second-Generation Gepants, and Cardiovascular Risk.
    Headache. 2019 Jul 18. doi: 10.1111/head.13601.
    PubMed     Abstract available


  145. LAW EF, Powers SW, Blume H, Palermo TM, et al
    Screening Family and Psychosocial Risk in Pediatric Migraine and Tension-Type Headache: Validation of the Psychosocial Assessment Tool (PAT).
    Headache. 2019 Jul 18. doi: 10.1111/head.13599.
    PubMed     Abstract available


  146. SPANOU I, Bougea A, Liakakis G, Rizonaki K, et al
    Relationship of Migraine and Tension-Type Headache With Hypothyroidism: A Literature Review.
    Headache. 2019 Jul 16. doi: 10.1111/head.13600.
    PubMed     Abstract available


  147. KRYMCHANTOWSKI AV, Krymchantowski AG, Jevoux C
    Sodium Divalproate in Low Alternating Daily Doses for Migraine Prevention: A Retrospective Study.
    Headache. 2019 Jul 1. doi: 10.1111/head.13579.
    PubMed     Abstract available


  148. BUSE DC, Greisman JD, Baigi K, Lipton RB, et al
    Migraine Progression: A Systematic Review. An Editorial Comment.
    Headache. 2019;59:974-976.
    PubMed    


  149. YUAN H, Spare NM, Silberstein SD
    Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
    Headache. 2019;59 Suppl 2:20-32.
    PubMed     Abstract available


  150. SCHWEDT TJ
    New and Emerging Treatments for the Acute and Preventive Therapy of Migraine and Other Headaches.
    Headache. 2019;59 Suppl 2:1-2.
    PubMed    


  151. BERTELS Z, Pradhan AAA
    Emerging Treatment Targets for Migraine and Other Headaches.
    Headache. 2019;59 Suppl 2:50-65.
    PubMed     Abstract available


  152. HALKER SINGH RB, Ailani J, Robbins MS
    Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache.
    Headache. 2019;59 Suppl 2:33-49.
    PubMed     Abstract available


  153. MORENO-AJONA D, Chan C, Villar-Martinez MD, Goadsby PJ, et al
    Targeting CGRP and 5-HT1F Receptors for the Acute Therapy of Migraine: A Literature Review.
    Headache. 2019;59 Suppl 2:3-19.
    PubMed     Abstract available


    June 2019
  154. GELFAND AA, Buse DC, Cabana MD, Grimes B, et al
    The Association Between Parental Migraine and Infant Colic: A Cross-Sectional, Web-Based, U.S. Survey Study.
    Headache. 2019 Jun 20. doi: 10.1111/head.13575.
    PubMed     Abstract available


  155. KAWATA AK, Hareendran A, Shaffer S, Mannix S, et al
    Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ).
    Headache. 2019 Jun 5. doi: 10.1111/head.13569.
    PubMed     Abstract available


  156. FARRIS SG, Burr EK, Abrantes AM, Thomas JG, et al
    Anxiety Sensitivity as a Risk Indicator for Anxiety, Depression, and Headache Severity in Women With Migraine.
    Headache. 2019 Jun 5. doi: 10.1111/head.13568.
    PubMed     Abstract available


  157. HALL AL, Karvounides D, Gelfand AA, Mankin H, et al
    Improving the Patient Experience With Migraine Camp, a One-Day Group Intervention for Adolescents With Chronic Headache and Their Parents.
    Headache. 2019 Jun 5. doi: 10.1111/head.13570.
    PubMed     Abstract available


  158. TEPPER SJ, Krege JH, Lombard L, Asafu-Adjei JK, et al
    Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials.
    Headache. 2019 Jun 1. doi: 10.1111/head.13544.
    PubMed     Abstract available


    May 2019
  159. ALAYDIN HC, Vuralli D, Keceli Y, Can E, et al
    Reduced Short-Latency Afferent Inhibition Indicates Impaired Sensorimotor Integrity During Migraine Attacks.
    Headache. 2019 May 20. doi: 10.1111/head.13554.
    PubMed     Abstract available


  160. YARNITSKY D, Dodick DW, Grosberg BM, Burstein R, et al
    Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
    Headache. 2019 May 9. doi: 10.1111/head.13551.
    PubMed     Abstract available


  161. SKAJAA N, Szepligeti SK, Xue F, Sorensen HT, et al
    Pregnancy, Birth, Neonatal, and Postnatal Neurological Outcomes After Pregnancy With Migraine.
    Headache. 2019 May 8. doi: 10.1111/head.13536.
    PubMed     Abstract available


  162. MCGINLEY JS, Buse DC, Shulman KJ, Wirth RJ, et al
    Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized Trial.
    Headache. 2019 May 7. doi: 10.1111/head.13530.
    PubMed     Abstract available


  163. BERGER A, Litwin J, Allen IE, Qubty W, et al
    Preliminary Evidence that Melatonin Is not a Biomarker With Children and Adolescents With Episodic Migraine.
    Headache. 2019 May 3. doi: 10.1111/head.13547.
    PubMed     Abstract available


  164. LIU L, Yu Y, He J, Guo L, et al
    Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies.
    Headache. 2019 May 2. doi: 10.1111/head.13540.
    PubMed     Abstract available


    April 2019
  165. YOUNG NP, Philpot LM, Vierkant RA, Rosedahl JK, et al
    Episodic and Chronic Migraine in Primary Care.
    Headache. 2019 Apr 29. doi: 10.1111/head.13543.
    PubMed     Abstract available


  166. HARGREAVES R, Olesen J
    Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Headache. 2019 Apr 25. doi: 10.1111/head.13510.
    PubMed     Abstract available


  167. GELFAND AA, Pavitt S, Greene K, Szperka CL, et al
    High School Start Time and Migraine Frequency in High School Students.
    Headache. 2019 Apr 24. doi: 10.1111/head.13535.
    PubMed     Abstract available


  168. GOLIKHATIR I, Cheraghmakani H, Bozorgi F, Jahanian F, et al
    The Efficacy and Safety of Prochlorperazine in Patients With Acute Migraine: A Systematic Review and Meta-Analysis.
    Headache. 2019 Apr 16. doi: 10.1111/head.13527.
    PubMed     Abstract available


  169. IYENGAR S, Johnson KW, Ossipov MH, Aurora SK, et al
    CGRP and the Trigeminal System in Migraine.
    Headache. 2019 Apr 14. doi: 10.1111/head.13529.
    PubMed     Abstract available


  170. SILBERSTEIN SD, McAllister P, Ning X, Faulhaber N, et al
    Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.
    Headache. 2019 Apr 12. doi: 10.1111/head.13534.
    PubMed     Abstract available


  171. KLAN T, Liesering-Latta E, Gaul C, Martin PR, et al
    An Integrative Cognitive Behavioral Therapy Program for Adults With Migraine: A Feasibility Study.
    Headache. 2019 Apr 10. doi: 10.1111/head.13532.
    PubMed     Abstract available


  172. HINDIYEH NA, Kellerman DJ, Schmidt PC
    Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials.
    Headache. 2019 Apr 6. doi: 10.1111/head.13511.
    PubMed     Abstract available


  173. STAUFFER VL, Wang S, Voulgaropoulos M, Skljarevski V, et al
    Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials.
    Headache. 2019 Apr 3. doi: 10.1111/head.13508.
    PubMed     Abstract available


  174. BOES CJ
    Comment on "Chronic Migraine - Evolution of the Concept and Clinical Implications".
    Headache. 2019;59:623.
    PubMed    


  175. ROSEN N, Pearlman E, Ruff D, Day K, et al
    Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine.
    Headache. 2019;59:627-628.
    PubMed    


  176. ANSARI H
    Choose Wisely: Adapt the Classification Characteristic for Migraine Trigger Points.
    Headache. 2019;59:621-622.
    PubMed    


  177. CHARLES JA, Rapoport AM
    The American Headache Society's Position Statement on Integrating New Migraine Treatments into Clinical Practice - Comments.
    Headache. 2019;59:629.
    PubMed    


  178. STEINER TJ, Tfelt-Hansen P
    Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic Migraine.
    Headache. 2019;59:626.
    PubMed    


  179. RIST PM, Hernandez A, Bernstein C, Kowalski M, et al
    The Impact of Spinal Manipulation on Migraine Pain and Disability: A Systematic Review and Meta-Analysis.
    Headache. 2019;59:532-542.
    PubMed     Abstract available


  180. COWAN RP
    Toward a Philosophy of Migraine.
    Headache. 2019;59:481-483.
    PubMed    


  181. VIGANO A, Manica A, Di Piero V, Leonardi M, et al
    Did Going North Give Us Migraine? An Evolutionary Approach on Understanding Latitudinal Differences in Migraine Epidemiology.
    Headache. 2019;59:632-634.
    PubMed     Abstract available


  182. RUSSO A, Silvestro M, Tessitore A, Tedeschi G, et al
    Recent Insights in Migraine With Aura: A Narrative Review of Advanced Neuroimaging.
    Headache. 2019;59:637-649.
    PubMed     Abstract available


    March 2019
  183. TRAHAN EM, Mercado JM
    Familial Hemiplegic Migraines and Baseline Neuropsychological Testing: A Case Report.
    Headache. 2019 Mar 14. doi: 10.1111/head.13505.
    PubMed     Abstract available


  184. SPECK RM, Shalhoub H, Wyrwich KW, Yu R, et al
    Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.
    Headache. 2019 Mar 12. doi: 10.1111/head.13497.
    PubMed     Abstract available


  185. MANSFIELD C, Gebben DJ, Sutphin J, Tepper SJ, et al
    Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Headache. 2019 Mar 12. doi: 10.1111/head.13498.
    PubMed     Abstract available


  186. YILDIZ FG, Turkyilmaz U, Unal-Cevik I
    The Clinical Characteristics and Neurophysiological Assessments of the Occipital Cortex in Visual Snow Syndrome With or Without Migraine.
    Headache. 2019 Mar 8. doi: 10.1111/head.13494.
    PubMed     Abstract available


  187. TEPPER DE
    Calcitonin Gene-Related Protein (CGRP)-Targeted Treatments for Migraine Prevention.
    Headache. 2019;59:477-480.
    PubMed    


    February 2019
  188. GRINBERG AS, Seng EK
    Cross-Sectional Evaluation of the Psychometric Properties of the Headache-Specific Locus of Control Scale in People With Migraine.
    Headache. 2019 Feb 19. doi: 10.1111/head.13485.
    PubMed     Abstract available


  189. BEH SC, Masrour S, Smith SV, Friedman DI, et al
    The Spectrum of Vestibular Migraine: Clinical Features, Triggers, and Examination Findings.
    Headache. 2019 Feb 8. doi: 10.1111/head.13484.
    PubMed     Abstract available


  190. HAYNE DP, Martin PR
    Relating Photophobia, Visual Aura, and Visual Triggers of Headache and Migraine.
    Headache. 2019 Feb 8. doi: 10.1111/head.13486.
    PubMed     Abstract available


    January 2019
  191. TEPPER SJ, Dodick DW, Schmidt PC, Kellerman DJ, et al
    Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Headache. 2019 Jan 30. doi: 10.1111/head.13482.
    PubMed     Abstract available


  192. ANDROULAKIS XM, Sen S, Kodumuri N, Zhang T, et al
    Migraine Age of Onset and Association With Ischemic Stroke in Late Life: 20 Years Follow-Up in ARIC.
    Headache. 2019 Jan 21. doi: 10.1111/head.13468.
    PubMed     Abstract available


  193. PERES MFP, Oliveira AB, Mercante JP, Kamei HH, et al
    Optimism, Pessimism, and Migraine: A Cross-Sectional, Population-Based Study.
    Headache. 2019 Jan 19. doi: 10.1111/head.13471.
    PubMed     Abstract available


  194. SONG TJ, Cho SJ, Kim WJ, Yang KI, et al
    Sex Differences in Prevalence, Symptoms, Impact, and Psychiatric Comorbidities in Migraine and Probable Migraine: A Population-Based Study.
    Headache. 2019 Jan 9. doi: 10.1111/head.13470.
    PubMed     Abstract available


  195. MANCINI V, Mastria G, Frantellizzi V, Troiani P, et al
    Migrainous Infarction in a Patient With Sporadic Hemiplegic Migraine and Cystic Fibrosis: A 99mTc-HMPAO Brain SPECT Study.
    Headache. 2019 Jan 8. doi: 10.1111/head.13472.
    PubMed     Abstract available


  196. YOUNG WB
    The Effect of Onabotulinum Toxin on Aura Frequency and Severity in Patients With Hemiplegic Migraine - A Comment.
    Headache. 2019;59:110.
    PubMed    


    December 2018
  197. BUSE DC, Greisman JD, Baigi K, Lipton RB, et al
    Migraine Progression: A Systematic Review.
    Headache. 2018 Dec 27. doi: 10.1111/head.13459.
    PubMed     Abstract available


  198. ROGANTE E, Sarubbi S, Lamis DA, Canzonetta V, et al
    Illness Perception and Job Satisfaction in Patients Suffering from Migraine Headaches: Trait Anxiety and Depressive Symptoms as Potential Mediators.
    Headache. 2018 Dec 13. doi: 10.1111/head.13461.
    PubMed     Abstract available



  199. The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice.
    Headache. 2018 Dec 10. doi: 10.1111/head.13456.
    PubMed     Abstract available


  200. MAGALHAES JE, Barros IML, Pedrosa RP, Sampaio Rocha-Filho PA, et al
    Migraine and Markers of Carotid Atherosclerosis in Middle-Aged Women: A Cross-Sectional Study.
    Headache. 2018 Dec 5. doi: 10.1111/head.13460.
    PubMed     Abstract available


    November 2018
  201. WOLDEAMANUEL YW, DeSouza DD, Sanjanwala BM, Cowan RP, et al
    Clinical Features Contributing to Cortical Thickness Changes in Chronic Migraine - A Pilot Study.
    Headache. 2018 Nov 23. doi: 10.1111/head.13452.
    PubMed     Abstract available


  202. NICHOLS R, Doty E, Sacco S, Ruff D, et al
    Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE-1, EVOLVE-2, and REGAIN Randomized, Double-Blind, Placebo-Controlled Studies.
    Headache. 2018 Nov 21. doi: 10.1111/head.13443.
    PubMed     Abstract available


  203. SILBERSTEIN SD, Rapoport AM, Loupe PS, Aycardi E, et al
    The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
    Headache. 2018 Nov 18. doi: 10.1111/head.13446.
    PubMed     Abstract available


  204. LIU Y, Li S, Wang R, Han X, et al
    A New Perspective of Migraine Symptoms in Patients With Congenital Heart Defect.
    Headache. 2018 Nov 16. doi: 10.1111/head.13453.
    PubMed     Abstract available


  205. KROON VAN DIEST AM, Powers SW
    Cognitive Behavioral Therapy for Pediatric Headache and Migraine: Why to Prescribe and What New Research Is Critical for Advancing Integrated Biobehavioral Care.
    Headache. 2018 Nov 16. doi: 10.1111/head.13438.
    PubMed     Abstract available


  206. LEVIN M, Silberstein SD, Gilbert R, Lucas S, et al
    Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
    Headache. 2018 Nov 13. doi: 10.1111/head.13439.
    PubMed     Abstract available


  207. HAMILTON KT, Robbins MS
    Migraine Treatment in Pregnant Women Presenting to Acute Care: A Retrospective Observational Study.
    Headache. 2018 Nov 7. doi: 10.1111/head.13434.
    PubMed     Abstract available


  208. BUSE DC, Rains JC, Pavlovic JM, Fanning KM, et al
    Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Headache. 2018 Nov 1. doi: 10.1111/head.13435.
    PubMed     Abstract available


    October 2018
  209. SENG EK, Mauser ED, Marzouk M, Patel ZS, et al
    When Mom Has Migraine: An Observational Study of the Impact of Parental Migraine on Adolescent Children.
    Headache. 2018 Oct 31. doi: 10.1111/head.13433.
    PubMed     Abstract available


  210. SILBERSTEIN SD, Lee L, Gandhi K, Fitzgerald T, et al
    Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Headache. 2018 Oct 30. doi: 10.1111/head.13421.
    PubMed     Abstract available


  211. HAREENDRAN A, Skalicky A, Mannix S, Lavoie S, et al
    Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Headache. 2018 Oct 30. doi: 10.1111/head.13420.
    PubMed     Abstract available


  212. LODER EW, Rayhill M, Burch RC
    Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process.
    Headache. 2018 Oct 27. doi: 10.1111/head.13424.
    PubMed     Abstract available


  213. SORGENFREI V, Kropp P, Straube A, Ruscheweyh R, et al
    High Achievement Motivation is Not Related to Increased Use of Acute Headache Medication in Migraine: A Cross-sectional Observational Cohort Study.
    Headache. 2018 Oct 27. doi: 10.1111/head.13431.
    PubMed     Abstract available


  214. MARISSA LAGMAN-BARTOLOME A, Lay C
    The Traffic Light of Headache: Simplifying Acute Migraine Management for Physicians and Patients Using the Canadian Headache Society Guidelines.
    Headache. 2018 Oct 27. doi: 10.1111/head.13428.
    PubMed     Abstract available


  215. TOGHA M, Razeghi Jahromi S, Ghorbani Z, Martami F, et al
    Serum Vitamin D Status in a Group of Migraine Patients Compared With Healthy Controls: A Case-Control Study.
    Headache. 2018 Oct 20. doi: 10.1111/head.13423.
    PubMed     Abstract available


  216. COWAN RP
    The Future of Migraine Prevention.
    Headache. 2018 Oct 12. doi: 10.1111/head.13418.
    PubMed     Abstract available


  217. DODICK DW, Tepper SJ, Lipton RB, Buse DC, et al
    Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
    Headache. 2018;58:1358-1372.
    PubMed     Abstract available


  218. ROSEN N, Pearlman E, Ruff D, Day K, et al
    100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies.
    Headache. 2018;58:1347-1357.
    PubMed     Abstract available


  219. LIPTON RB, Munjal S, Alam A, Buse DC, et al
    Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Headache. 2018;58:1408-1426.
    PubMed     Abstract available


    September 2018
  220. SCHINDLER EAD, Wright DA, Weil MJ, Gottschalk CH, et al
    Survey Analysis of the Use, Effectiveness, and Patient-Reported Tolerability of Inhaled Oxygen Compared With Injectable Sumatriptan for the Acute Treatment of Cluster Headache.
    Headache. 2018 Sep 17. doi: 10.1111/head.13405.
    PubMed     Abstract available


  221. WIELS W, Ourtani A, Van Binst AM, De Raedt S, et al
    Migrainous Headache Accompanied by Hemi-Atrophy of the Tongue in Carotid Artery Dissection.
    Headache. 2018 Sep 17. doi: 10.1111/head.13412.
    PubMed    


  222. BERNSTEIN C, Shifren J, Maleki N
    Need for Migraine/Perimenopausal Research.
    Headache. 2018 Sep 8. doi: 10.1111/head.13406.
    PubMed    


  223. MEDREA I, Christi S
    Chronic Migraine - Evolution of the Concept and Clinical Implications.
    Headache. 2018 Sep 4. doi: 10.1111/head.13380.
    PubMed     Abstract available


  224. DE RU JA
    Choose Wisely: Adapt the Classification Characteristics for "Migraine Trigger Points".
    Headache. 2018;58:1256.
    PubMed    


    August 2018
  225. HOWARD L, Dumkrieger G, Chong CD, Ross K, et al
    Symptoms of Autonomic Dysfunction Among Those With Persistent Posttraumatic Headache Attributed to Mild Traumatic Brain Injury: A Comparison to Migraine and Healthy Controls.
    Headache. 2018 Aug 29. doi: 10.1111/head.13396.
    PubMed     Abstract available


  226. FRIEDMAN BW, Mohamed S, Robbins MS, Irizarry E, et al
    A Randomized, Sham-Controlled Trial of Bilateral Greater Occipital Nerve Blocks With Bupivacaine for Acute Migraine Patients Refractory to Standard Emergency Department Treatment With Metoclopramide.
    Headache. 2018 Aug 25. doi: 10.1111/head.13395.
    PubMed     Abstract available


  227. LODER E, Rizzoli P
    Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018.
    Headache. 2018 Aug 23. doi: 10.1111/head.13375.
    PubMed     Abstract available


  228. BENORE E, Webster EE, Wang L, Banez G, et al
    Longitudinal Analysis of Patient-Reported Outcomes From an Interdisciplinary Pediatric Pain Rehabilitation Program for Children With Chronic Migraine and Headache.
    Headache. 2018 Aug 23. doi: 10.1111/head.13389.
    PubMed     Abstract available


  229. SCARATTI C, Covelli V, Guastafierro E, Leonardi M, et al
    A Qualitative Study On Patients With Chronic Migraine With Medication Overuse Headache: Comparing Frequent And Non-Frequent Relapsers.
    Headache. 2018 Aug 20. doi: 10.1111/head.13385.
    PubMed     Abstract available


  230. MAGALHAES JE, Sampaio Rocha-Filho PA
    Migraine and cerebrovascular diseases: Epidemiology, pathophysiological, and clinical considerations.
    Headache. 2018 Aug 17. doi: 10.1111/head.13378.
    PubMed     Abstract available


  231. QURESHI AI, Naseem N, Saleem MA, Potluri A, et al
    Migraine and Non-Migraine Headaches Following Diagnostic Catheter-Based Cerebral Angiography.
    Headache. 2018 Aug 16. doi: 10.1111/head.13377.
    PubMed     Abstract available


  232. AYER DW, Skljarevski V, Ford JH, Nyhuis AW, et al
    Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab.
    Headache. 2018 Aug 14. doi: 10.1111/head.13383.
    PubMed     Abstract available


  233. RAINS JC
    Sleep and Migraine: Assessment and Treatment of Comorbid Sleep Disorders.
    Headache. 2018 Aug 10. doi: 10.1111/head.13357.
    PubMed     Abstract available


  234. VGONTZAS A, Pavlovic JM
    Sleep Disorders and Migraine: Review of Literature and Potential Pathophysiology Mechanisms.
    Headache. 2018 Aug 8. doi: 10.1111/head.13358.
    PubMed     Abstract available


    July 2018
  235. MEHTA D, Leary MC, Yacoub HA, El-Hunjul M, et al
    The Effect of Regional Anesthetic Sphenopalatine Ganglion Block on Self-Reported Pain in Patients With Status Migrainosus.
    Headache. 2018 Jul 25. doi: 10.1111/head.13390.
    PubMed     Abstract available


  236. CADY R, Lipton RB
    Qualitative Change in Migraine Prevention?
    Headache. 2018 Jul 23. doi: 10.1111/head.13354.
    PubMed     Abstract available


  237. OLIVER JD, Boesch RP, Mack KJ
    Decreased Pulmonary Function During Botulinum Toxin A Therapy for Chronic Migraines in a 17-Year-Old Female.
    Headache. 2018 Jul 22. doi: 10.1111/head.13359.
    PubMed    


  238. LIPTON RB, Fanning KM, Buse DC, Martin VT, et al
    Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Headache. 2018 Jul 19. doi: 10.1111/head.13342.
    PubMed     Abstract available


  239. MINEN MT, Stieglitz EJ, Sciortino R, Torous J, et al
    Privacy Issues in Smartphone Applications: An Analysis of Headache/Migraine Applications.
    Headache. 2018 Jul 4. doi: 10.1111/head.13341.
    PubMed     Abstract available


  240. LAW EF, Wan Tham S, Aaron RV, Dudeney J, et al
    Hybrid Cognitive-Behavioral Therapy Intervention for Adolescents With Co-Occurring Migraine and Insomnia: A Single-Arm Pilot Trial.
    Headache. 2018;58:1060-1073.
    PubMed     Abstract available


  241. SMITHERMAN TA
    Foreword: Special Collection on Sleep Disorders and Migraine.
    Headache. 2018;58:1028-1029.
    PubMed    


  242. BEH SC
    Horizontal Direction-Changing Positional Nystagmus and Vertigo: A Case of Vestibular Migraine Masquerading as Horizontal Canal BPPV.
    Headache. 2018;58:1113-1117.
    PubMed     Abstract available


  243. BARON EP
    Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
    Headache. 2018;58:1139-1186.
    PubMed     Abstract available


  244. MAGGIONI F
    When Can We, Really, Talk About Status Migrainosus in Migraine With Aura?
    Headache. 2018;58:1120-1121.
    PubMed    


    June 2018
  245. VELICKOVIC OSTOJIC L, Liang JW, Sheikh HU, Dhamoon MS, et al
    Impact of Aura and Status Migrainosus on Readmissions for Vascular Events After Migraine Admission.
    Headache. 2018 Jun 22. doi: 10.1111/head.13347.
    PubMed     Abstract available


  246. ORR SL, Kabbouche MA, Horn PS, O'Brien HL, et al
    Predictors of First-Line Treatment Success in Children and Adolescents Visiting an Infusion Center for Acute Migraine.
    Headache. 2018 Jun 21. doi: 10.1111/head.13340.
    PubMed     Abstract available


  247. HANSON LL, Ahmed Z, Katz BJ, Warner JEA, et al
    Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life.
    Headache. 2018 Jun 7. doi: 10.1111/head.13330.
    PubMed     Abstract available


  248. SENG EK, Kuka AJ, Mayson SJ, Smitherman TA, et al
    Acceptance, Psychiatric Symptoms, and Migraine Disability: An Observational Study in a Headache Center.
    Headache. 2018;58:859-872.
    PubMed     Abstract available


    May 2018
  249. DODICK DW, Tepper SJ, Friedman DI, Gelfand AA, et al
    Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
    Headache. 2018 May 21. doi: 10.1111/head.13327.
    PubMed     Abstract available


  250. EVANS RW
    Post traumatic Episodic Status Migrainosus.
    Headache. 2018 May 20. doi: 10.1111/head.13326.
    PubMed    


  251. CHEN TY, Garza I, Dodick DW, Robertson CE, et al
    The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients.
    Headache. 2018 May 15. doi: 10.1111/head.13317.
    PubMed     Abstract available


  252. SMITHERMAN TA, Kuka AJ, Calhoun AH, Walters ABP, et al
    Cognitive-Behavioral Therapy for Insomnia to Reduce Chronic Migraine: A Sequential Bayesian Analysis.
    Headache. 2018 May 6. doi: 10.1111/head.13313.
    PubMed     Abstract available


  253. BUSE DC, Gillard P, Arctander K, Kuang AW, et al
    Assessing Physician-Patient Dialogues About Chronic Migraine During Routine Office Visits.
    Headache. 2018 May 4. doi: 10.1111/head.13314.
    PubMed     Abstract available


  254. ONG JC, Taylor HL, Park M, Burgess HJ, et al
    Can Circadian Dysregulation Exacerbate Migraines?
    Headache. 2018 May 4. doi: 10.1111/head.13310.
    PubMed     Abstract available


  255. REUTER U
    A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine.
    Headache. 2018;58 Suppl 1:48-59.
    PubMed     Abstract available


  256. HOLLAND PR
    Foreword: The CGRP Pathway and Migraine Prevention: Reducing the Burden of Disease.
    Headache. 2018;58 Suppl 1:1-3.
    PubMed    


  257. DODICK DW
    A Phase-by-Phase Review of Migraine Pathophysiology.
    Headache. 2018;58 Suppl 1:4-16.
    PubMed     Abstract available


  258. EDVINSSON L
    The CGRP Pathway in Migraine as a Viable Target for Therapies.
    Headache. 2018;58 Suppl 1:33-47.
    PubMed     Abstract available


  259. AGOSTI R
    Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View.
    Headache. 2018;58 Suppl 1:17-32.
    PubMed     Abstract available


  260. KREBS K, Rorden C, Androulakis XM
    Resting State Functional Connectivity After Sphenopalatine Ganglion Blocks in Chronic Migraine With Medication Overuse Headache: A Pilot Longitudinal fMRI Study.
    Headache. 2018;58:732-743.
    PubMed     Abstract available


  261. CHARLESTON L 4TH, Royce J, Monteith TS, Broner SW, et al
    Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 2.
    Headache. 2018;58:633-647.
    PubMed     Abstract available


  262. LIPTON RB, Munjal S, Brand-Schieber E, Rapoport AM, et al
    DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Headache. 2018;58:676-687.
    PubMed     Abstract available


    April 2018
  263. BEH SC
    A Case of Vestibular Migraine Resolving on Warfarin and Topiramate.
    Headache. 2018;58:599-600.
    PubMed    


  264. TEPPER SJ
    Editorial: Understanding Menstrual Migraine.
    Headache. 2018;58:625.
    PubMed    


  265. LUIZON MR, Goncalves FM, Dach F
    Gene-Gene Interactions Implicated in Vascular Endothelial Function in Migraine.
    Headache. 2018;58:601-602.
    PubMed    


    March 2018
  266. IRWIN SL, Qubty W, Allen IE, Patniyot I, et al
    Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.
    Headache. 2018 Mar 12. doi: 10.1111/head.13284.
    PubMed     Abstract available


  267. BURCH R, Rizzoli P, Loder E
    The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies.
    Headache. 2018 Mar 12. doi: 10.1111/head.13281.
    PubMed     Abstract available


  268. FRIEDMAN BW, Latev A, Campbell C, White D, et al
    Opioid-Induced "Likeability" and "Feeling Good" Are Not Associated With Return Visits to an ED Among Migraine Patients Administered IV Hydromorphone.
    Headache. 2018 Mar 8. doi: 10.1111/head.13292.
    PubMed     Abstract available


  269. KROON VAN DIEST AM, Ernst MM, Vaughn L, Slater S, et al
    CBT for Pediatric Migraine: A Qualitative Study of Patient and Parent Experience.
    Headache. 2018 Mar 8. doi: 10.1111/head.13285.
    PubMed     Abstract available


  270. CHARLESTON L 4TH, Royce J, Monteith TS, Broner SW, et al
    Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review, Part 1.
    Headache. 2018 Mar 8. doi: 10.1111/head.13286.
    PubMed     Abstract available


  271. PURDY RA
    Neurobiological Basis of Migraine.
    Headache. 2018 Mar 6. doi: 10.1111/head.13296.
    PubMed    


  272. CALHOUN AH
    Understanding Menstrual Migraine.
    Headache. 2018 Mar 1. doi: 10.1111/head.13291.
    PubMed     Abstract available


    February 2018
  273. SINGH AS
    Mirror Induced Headaches: A New Self Image Trigger for Migraine Attacks?
    Headache. 2018 Feb 28. doi: 10.1111/head.13293.
    PubMed    


  274. BONAFEDE M, Sapra S, Shah N, Tepper S, et al
    Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Headache. 2018 Feb 15. doi: 10.1111/head.13275.
    PubMed     Abstract available


  275. PERETZ AM, Minen MT, Cowan R, Strauss LD, et al
    Introducing the Migraine Action Plan.
    Headache. 2018;58:195.
    PubMed    


  276. LEIVA-CALDERON A, Mayorga-Moreno RJ
    Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study: A Comment.
    Headache. 2018;58:309-310.
    PubMed    


  277. CHO SJ, Sohn JH, Bae JS, Chu MK, et al
    Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study - A Response.
    Headache. 2018;58:311-312.
    PubMed    


  278. PERETZ AM, Minen MT, Cowan R, Strauss LD, et al
    Migraine Action Plan (MAP).
    Headache. 2018;58:355-356.
    PubMed    


  279. PERCIACCANTE A, Abenavoli L, Coralli A, Charlier P, et al
    The Complex Aura of Nikola Tesla.
    Headache. 2018;58:304-305.
    PubMed    


  280. WEI DY, Greenwood FS, Murgatroyd FD, Goadsby PJ, et al
    Case Report of the Safety Assessment of Transcranial Magnetic Stimulation Use in a Patient With Cardiac Pacemaker: To Pulse or Not to Pulse?
    Headache. 2018;58:295-297.
    PubMed     Abstract available


  281. REDON S, Donnet A
    Sneezing in Primary Headaches With Cranial Autonomic Symptoms: Pathophysiological Considerations. A Series of Case Reports.
    Headache. 2018;58:298-303.
    PubMed     Abstract available


  282. RABNER J, Kaczynski KJ, Simons LE, LeBel A, et al
    Pediatric Headache and Sleep Disturbance: A Comparison of Diagnostic Groups.
    Headache. 2018;58:217-228.
    PubMed     Abstract available


    January 2018
  283. BUSE DC, Powers SW, Gelfand AA, VanderPluym JH, et al
    Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study.
    Headache. 2018 Jan 22. doi: 10.1111/head.13254.
    PubMed     Abstract available


  284. PURDY RA
    Understanding Your Migraines: A Guide for Patients and Families.
    Headache. 2018 Jan 9. doi: 10.1111/head.13251.
    PubMed    


  285. SHIPKOV H, Grozdev I
    Injection Patterns of Onabotulinumtoxin A in Migraine Headache.
    Headache. 2018;58:148-150.
    PubMed    


  286. MAASUMI K, Tepper SJ, Kriegler JS
    Menstrual Migraine and Treatment Options-A Response.
    Headache. 2018;58:147.
    PubMed    


  287. LICHTEN EM
    Menstrual Migraine and Treatment Options: Review.
    Headache. 2018;58:145-146.
    PubMed    


  288. LUNA S, Lai D, Harris A
    Antagonistic Relationship Between VEP Potentiation and Gamma Power in Visual Snow Syndrome.
    Headache. 2018;58:138-144.
    PubMed     Abstract available


  289. ALSTADHAUG KB, Ofte HK
    Spot On?
    Headache. 2018;58:136-137.
    PubMed    


    December 2017
  290. DE RIJK P, Resseguier N, Donnet A
    Headache Characteristics and Clinical Features of Elderly Migraine Patients.
    Headache. 2017 Dec 13. doi: 10.1111/head.13247.
    PubMed     Abstract available


  291. TEGGI R, Colombo B, Albera R, Asprella Libonati G, et al
    Clinical Features, Familial History, and Migraine Precursors in Patients With Definite Vestibular Migraine: The VM-Phenotypes Projects.
    Headache. 2017 Dec 4. doi: 10.1111/head.13240.
    PubMed     Abstract available


    November 2017
  292. FRIEDMAN LE, Zhong QY, Gelaye B, Williams MA, et al
    Association Between Migraine and Suicidal Behaviors: A Nationwide Study in the USA.
    Headache. 2017 Nov 29. doi: 10.1111/head.13235.
    PubMed     Abstract available


  293. MINEN MT, Anglin L, Boubour A, Squires A, et al
    Meta-Synthesis on Migraine Management.
    Headache. 2017 Nov 21. doi: 10.1111/head.13212.
    PubMed     Abstract available


  294. SHEIKH HU, Pavlovic J, Loder E, Burch R, et al
    Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review.
    Headache. 2017 Nov 15. doi: 10.1111/head.13229.
    PubMed     Abstract available


  295. YOUNG WB
    De-Stigmatizing Migraine - With Words.
    Headache. 2017 Nov 15. doi: 10.1111/head.13209.
    PubMed    


  296. DOMINGUEZ C, Vieites-Prado A, Perez-Mato M, Sobrino T, et al
    CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.
    Headache. 2017 Nov 13. doi: 10.1111/head.13211.
    PubMed     Abstract available


  297. VON LUCKNER A, Riederer F
    Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.
    Headache. 2017 Nov 13. doi: 10.1111/head.13217.
    PubMed     Abstract available


  298. YOU DS, Haney R, Albu S, Meagher MW, et al
    Generalized Pain Sensitization and Endogenous Oxytocin in Individuals With Symptoms of Migraine: A Cross-Sectional Study.
    Headache. 2017 Nov 2. doi: 10.1111/head.13213.
    PubMed     Abstract available


  299. MINEN MT, Boubour A, Wahnich A, Grudzen C, et al
    A Retrospective Nested Cohort Study of Emergency Department Revisits for Migraine in New York City.
    Headache. 2017 Nov 2. doi: 10.1111/head.13216.
    PubMed     Abstract available


  300. OSUMILI B, McCrone P, Cousins S, Ridsdale L, et al
    The Economic Cost of Patients With Migraine Headache Referred to Specialist Clinics.
    Headache. 2017 Nov 2. doi: 10.1111/head.13210.
    PubMed     Abstract available


  301. FERDINANDO M, Alberto T, Giuseppe M, Federico M, et al
    Combination of NSAID and Triptan in Migraine Treatment and Cardiovascular Risk: Is It Safe?
    Headache. 2017;57:1622-1623.
    PubMed    


    October 2017
  302. CHU HT, Liang CS, Lee JT, Yeh TC, et al
    Associations Between Depression/Anxiety and Headache Frequency in Migraineurs: A Cross-Sectional Study.
    Headache. 2017 Oct 18. doi: 10.1111/head.13215.
    PubMed     Abstract available


  303. BORKUM JM
    The Migraine Attack as a Homeostatic, Neuroprotective Response to Brain Oxidative Stress: Preliminary Evidence for a Theory.
    Headache. 2017 Oct 16. doi: 10.1111/head.13214.
    PubMed     Abstract available


  304. LIPTON RB, McGinley JS, Shulman KJ, Silberstein SD, et al
    AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial.
    Headache. 2017 Oct 16. doi: 10.1111/head.13199.
    PubMed     Abstract available


  305. KARMAKAR M, Elhai JD, Amialchuk AA, Tietjen GE, et al
    Do Personality Traits Mediate the Relationship Between Childhood Abuse and Migraine? An Exploration of the Relationships in Young Adults Using the Add Health Dataset.
    Headache. 2017 Oct 13. doi: 10.1111/head.13206.
    PubMed     Abstract available


  306. LIPTON RB, Reed ML, Kurth T, Fanning KM, et al
    Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Headache. 2017 Oct 9. doi: 10.1111/head.13179.
    PubMed     Abstract available


  307. FORD JH, Jackson J, Milligan G, Cotton S, et al
    A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns.
    Headache. 2017 Oct 6. doi: 10.1111/head.13202.
    PubMed     Abstract available


  308. CHONG CD, Dumkrieger GM, Schwedt TJ
    Structural Co-Variance Patterns in Migraine: A Cross-Sectional Study Exploring the Role of the Hippocampus.
    Headache. 2017 Oct 4. doi: 10.1111/head.13193.
    PubMed     Abstract available


  309. KRASENBAUM LJ
    A Review of Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
    Headache. 2017;57:1451-1452.
    PubMed    


    September 2017
  310. GUVEN B, Guven H, Comoglu SS
    Migraine and Yawning.
    Headache. 2017 Sep 27. doi: 10.1111/head.13195.
    PubMed     Abstract available


  311. NILSSON BG, Bungard TJ
    A Case of Migraine With Aura Resolving on Warfarin But Not on Apixaban.
    Headache. 2017 Sep 27. doi: 10.1111/head.13190.
    PubMed     Abstract available


  312. ROGALINSKI S, Rambold HA
    Probing Early Motion Processing With Eye Movements: Differences of Vestibular Migraine, Migraine With and Without Aura in the Attack Free Interval.
    Headache. 2017 Sep 25. doi: 10.1111/head.13185.
    PubMed     Abstract available


  313. CHO SJ, Sohn JH, Bae JS, Chu MK, et al
    Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study.
    Headache. 2017 Sep 22. doi: 10.1111/head.13191.
    PubMed     Abstract available


  314. LEROUX E, Beaudet L, Boudreau G, Eghtesadi M, et al
    A Nursing Intervention Increases Quality of Life and Self-Efficacy in Migraine: A 1-Year Prospective Controlled Trial.
    Headache. 2017 Sep 15. doi: 10.1111/head.13178.
    PubMed     Abstract available


  315. LIPTON RB, McGinley JS, Shulman KJ, Wirth RJ, et al
    Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from th
    Headache. 2017 Sep 7. doi: 10.1111/head.13165.
    PubMed     Abstract available


  316. YUAN H, Silberstein SD
    Histamine and Migraine.
    Headache. 2017 Sep 1. doi: 10.1111/head.13164.
    PubMed     Abstract available


  317. COHEN JM, Dodick DW, Yang R, Newman LC, et al
    Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
    Headache. 2017 Sep 1. doi: 10.1111/head.13156.
    PubMed     Abstract available


  318. KRASENBAUM LJ
    A Review of Complementary and Alternative Medicine Use Among U.S. Adults with Headache or Migraine: Results from the 2012 National Health Interview Survey.
    Headache. 2017;57:1284-1285.
    PubMed    


    August 2017
  319. KAWATA AK, Hsieh R, Bender R, Shaffer S, et al
    Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
    Headache. 2017 Aug 30. doi: 10.1111/head.13162.
    PubMed     Abstract available


  320. WOOLLEY JM, Bonafede MM, Maiese BA, Lenz RA, et al
    Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
    Headache. 2017 Aug 26. doi: 10.1111/head.13157.
    PubMed     Abstract available


  321. BERGMAN-BOCK S
    Associations Between Migraine and the Most Common Psychiatric Co-Morbidities.
    Headache. 2017 Aug 10. doi: 10.1111/head.13146.
    PubMed     Abstract available


    July 2017
  322. SAMPAIO ROCHA-FILHO PA, Hershey AD
    Pediatric Migraine Disability Assessment (PedMIDAS): Translation Into Brazilian Portuguese and Cross-Cultural Adaptation.
    Headache. 2017 Jul 28. doi: 10.1111/head.13159.
    PubMed     Abstract available


  323. ZHANG Y, Dennis JA, Leach MJ, Bishop FL, et al
    Complementary and Alternative Medicine Use Among US Adults With Headache or Migraine: Results from the 2012 National Health Interview Survey.
    Headache. 2017 Jul 25. doi: 10.1111/head.13148.
    PubMed     Abstract available


  324. VALENTE M, Janes F, Russo V, Fontana A, et al
    Prevalence of Restless Legs Syndrome in Migraine Patients: A Case-Control Study. Analysis of Risk Factors for Restless Legs Syndrome in Migraine Patients.
    Headache. 2017;57:1088-1095.
    PubMed     Abstract available


  325. LIPTON RB, Pavlovic JM, Buse DC
    Why Migraine Forecasting Matters.
    Headache. 2017;57:1023-1025.
    PubMed    


  326. KRASENBAUM LJ
    A Review of Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results From the American Migraine Prevalence and Prevention Study.
    Headache. 2017;57:1156-1157.
    PubMed    


  327. HOULE TT, Turner DP, Golding AN, Porter JAH, et al
    Forecasting Individual Headache Attacks Using Perceived Stress: Development of a Multivariable Prediction Model for Persons With Episodic Migraine.
    Headache. 2017;57:1041-1050.
    PubMed     Abstract available


  328. GARCIA-MARTIN E, Martinez C, Serrador M, Alonso-Navarro H, et al
    Gamma-Aminobutyric Acid (Gaba) Receptors Rho (Gabrr) Gene Polymorphisms and Risk for Migraine.
    Headache. 2017;57:1118-1135.
    PubMed     Abstract available


    June 2017
  329. BURNS SM, Turner DP, Sexton KE, Deng H, et al
    Using Search Engines to Investigate Shared Migraine Experiences.
    Headache. 2017 Jun 28. doi: 10.1111/head.13130.
    PubMed     Abstract available


  330. WILKINSON D, Ade KK, Rogers LL, Attix DK, et al
    Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial.
    Headache. 2017 Jun 27. doi: 10.1111/head.13120.
    PubMed     Abstract available


  331. YADAV P, Bradley AL, Smith JH
    Recognition of Chronic Migraine by Medicine Trainees: A Cross-Sectional Survey.
    Headache. 2017 Jun 26. doi: 10.1111/head.13133.
    PubMed     Abstract available


  332. BEKKELUND SI, Muller KI, Wilhelmsen A, Alstadhaug KB, et al
    Photophobia and Seasonal Variation of Migraine in a Subarctic Population.
    Headache. 2017 Jun 19. doi: 10.1111/head.13131.
    PubMed     Abstract available


  333. SCHWEDT TJ, Si B, Li J, Wu T, et al
    Migraine Subclassification via a Data-Driven Automated Approach Using Multimodality Factor Mixture Modeling of Brain Structure Measurements.
    Headache. 2017 Jun 19. doi: 10.1111/head.13121.
    PubMed     Abstract available


  334. LIPTON RB, Munjal S, Buse DC, Bennett A, et al
    Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
    Headache. 2017 Jun 11. doi: 10.1111/head.13115.
    PubMed     Abstract available


  335. AMBROSINI A, D'Onofrio M, Buzzi MG, Arisi I, et al
    Possible Involvement of the CACNA1E Gene in Migraine: A Search for Single Nucleotide Polymorphism in Different Clinical Phenotypes.
    Headache. 2017 Jun 1. doi: 10.1111/head.13107.
    PubMed     Abstract available


  336. SCHULTE L, May A
    Pearls and Pitfalls in Migraine Neuroimaging.
    Headache. 2017;57:850-851.
    PubMed    


  337. KRASENBAUM LJ
    A Review of Vomiting and Migraine-Related Clinical Parameters in Pediatric Migraine.
    Headache. 2017;57:979-980.
    PubMed    


  338. TEPPER DE
    Migraine in Children.
    Headache. 2017;57:1021-1022.
    PubMed    


    May 2017
  339. BECKER WJ
    The Diagnosis and Management of Chronic Migraine in Primary Care.
    Headache. 2017 May 26. doi: 10.1111/head.13089.
    PubMed     Abstract available


  340. VAN DEN BERG JSP, Steiner TJ, Veenstra PJL, Kollen BJ, et al
    Migraine Nurses in Primary Care: Costs and Benefits.
    Headache. 2017 May 19. doi: 10.1111/head.13098.
    PubMed     Abstract available


  341. KISSOON NR, Cutrer FM
    Aura and Other Neurologic Dysfunction in or with Migraine.
    Headache. 2017 May 19. doi: 10.1111/head.13101.
    PubMed     Abstract available


  342. BURNS R, De Malherbe M, Chadenat ML, Pico F, et al
    Arterial Spin-Labeled MR Imaging Detecting Biphasic Neurovascular Changes in Migraine With Persistent Aura.
    Headache. 2017 May 19. doi: 10.1111/head.13119.
    PubMed    


  343. SILBERSTEIN S, Winner PK, McAllister PJ, Tepper SJ, et al
    Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered(R) Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
    Headache. 2017 May 11. doi: 10.1111/head.13105.
    PubMed     Abstract available


  344. HARTL E, Gonzalez-Victores JA, Remi J, Schankin CJ, et al
    Visual Auras in Epilepsy and Migraine - An Analysis of Clinical Characteristics.
    Headache. 2017 May 10. doi: 10.1111/head.13113.
    PubMed     Abstract available


  345. PERROTTA A, Anastasio MG, De Icco R, Coppola G, et al
    Frequency-Dependent Habituation Deficit of the Nociceptive Blink Reflex in Aura With Migraine Headache. Can Migraine Aura Modulate Trigeminal Excitability?
    Headache. 2017 May 10. doi: 10.1111/head.13111.
    PubMed     Abstract available


  346. EIDLITZ-MARKUS T, Haimi-Cohen Y, Zeharia A
    Vomiting and migraine-related clinical parameters in pediatric migraine.
    Headache. 2017 May 7. doi: 10.1111/head.13109.
    PubMed     Abstract available


  347. SHAYESTAGUL NA, Christensen CE, Amin FM, Ashina S, et al
    Measurement of Blood Flow Velocity in the Middle Cerebral Artery During Spontaneous Migraine Attacks: A Systematic Review.
    Headache. 2017 May 3. doi: 10.1111/head.13106.
    PubMed     Abstract available


  348. LENDVAI IS, Kinfe TM
    Migraine Improvement After Anterior Thalamic Deep Brain Stimulation for Drug-Resistant Idiopathic Generalized Seizure: A Case Report.
    Headache. 2017 May 2. doi: 10.1111/head.13097.
    PubMed    


  349. MAGGIONI F, Terrin A, Maggioni G, Mainardi F, et al
    Olfactory Modifications in a Migraine Patient With Anosmia.
    Headache. 2017;57:801-802.
    PubMed    


  350. EDVINSSON L
    The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
    Headache. 2017;57 Suppl 2:47-55.
    PubMed     Abstract available


  351. TZABAZIS A, Kori S, Mechanic J, Miller J, et al
    Oxytocin and Migraine Headache.
    Headache. 2017;57 Suppl 2:64-75.
    PubMed     Abstract available


  352. VOLLESEN ALH, Ashina M
    PACAP38: Emerging Drug Target in Migraine and Cluster Headache.
    Headache. 2017;57 Suppl 2:56-63.
    PubMed     Abstract available


  353. NOSEDA R, Borsook D, Burstein R
    Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache.
    Headache. 2017;57 Suppl 2:97-111.
    PubMed     Abstract available


  354. BLUMENFELD AM, Silberstein SD, Dodick DW, Aurora SK, et al
    Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.
    Headache. 2017;57:766-777.
    PubMed     Abstract available


  355. EVANS RW
    Incidental Findings and Normal Anatomical Variants on MRI of the Brain in Adults for Primary Headaches.
    Headache. 2017;57:780-791.
    PubMed     Abstract available


  356. FINKEL AG, Ivins BJ, Yerry JA, Klaric JS, et al
    Which Matters More? A Retrospective Cohort Study of Headache Characteristics and Diagnosis Type in Soldiers with mTBI/Concussion.
    Headache. 2017;57:719-728.
    PubMed     Abstract available


    April 2017
  357. RUSSO A, Silvestro M, Tessitore A, Tedeschi G, et al
    "Forced Normalization": Could It Occur Also in Migraine Patients?
    Headache. 2017 Apr 8. doi: 10.1111/head.13079.
    PubMed    


  358. LIPTON RB, Schmidt P, Diener HC
    Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.
    Headache. 2017 Apr 6. doi: 10.1111/head.13073.
    PubMed     Abstract available


  359. HAY DL, Walker CS
    CGRP and its receptors.
    Headache. 2017;57:625-636.
    PubMed     Abstract available


    March 2017
  360. LAW-YE B, Fargeot G, Leclercq D
    Arterial Spin Labeling Hypoperfusion in Migraine Aura.
    Headache. 2017 Mar 31. doi: 10.1111/head.13072.
    PubMed    


  361. OINONEN SM
    Integrative Medicine: A Necessary Component in Completing Treatment for My Chronic Migraines.
    Headache. 2017 Mar 22. doi: 10.1111/head.13070.
    PubMed    


  362. LILLIS J, Graham Thomas J, Seng EK, Lipton RB, et al
    Importance of Pain Acceptance in Relation to Headache Disability and Pain Interference in Women With Migraine and Overweight/Obesity.
    Headache. 2017 Mar 13. doi: 10.1111/head.13058.
    PubMed     Abstract available


  363. PULEDDA F, Goadsby PJ
    An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine.
    Headache. 2017 Mar 13. doi: 10.1111/head.13069.
    PubMed     Abstract available


  364. SUTHERLAND HG, Griffiths LR
    Genetics of Migraine: Insights into the Molecular Basis of Migraine Disorders.
    Headache. 2017 Mar 8. doi: 10.1111/head.13053.
    PubMed     Abstract available


  365. ALI A, Rothner AD
    Migraine With Neurological Features in a Scuba Diver With a Patent Foramen Ovale.
    Headache. 2017 Mar 2. doi: 10.1111/head.13047.
    PubMed     Abstract available


  366. SILVA-NETO RP, Almeida Soares A
    Does Migraine Occur Only in Humans or Other Animals May Suffer from This Disease Too?
    Headache. 2017;57:487.
    PubMed    


  367. KRASENBAUM LJ
    A Review of "Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study".
    Headache. 2017;57:500-501.
    PubMed    


  368. BUETTNER C, Melo-Carrillo A, Burstein R
    Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial.
    Headache. 2017;57:478-486.
    PubMed    


    February 2017
  369. ORR SL, Ramsay T, Christie SN, Dodick D, et al
    The Non-Inferiority Margins in Migraine Research (NIMM) Survey.
    Headache. 2017 Feb 11. doi: 10.1111/head.13048.
    PubMed     Abstract available


  370. LIPTON RB, Buse DC, Adams AM, Varon SF, et al
    Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale.
    Headache. 2017 Feb 10. doi: 10.1111/head.13028.
    PubMed     Abstract available


  371. FRIEDMAN DI, Evans RW
    Are Blurred Vision and Short-Duration Visual Phenomena Migraine Aura Symptoms?
    Headache. 2017 Feb 9. doi: 10.1111/head.13042.
    PubMed    


  372. SHABAS D, Sheikh HU, Gilad R
    Pituitary Apoplexy Presenting as Status Migrainosus.
    Headache. 2017 Feb 9. doi: 10.1111/head.13046.
    PubMed    


  373. TIETJEN GE, Collins SA
    Hypercoagulability and Migraine.
    Headache. 2017 Feb 9. doi: 10.1111/head.13044.
    PubMed     Abstract available


  374. AUPIAIS C, Wanin S, Romanello S, Spiri D, et al
    Association Between Migraine and Atopic Diseases in Childhood: A Potential Protective Role of Anti-Allergic Drugs.
    Headache. 2017 Feb 4. doi: 10.1111/head.13032.
    PubMed     Abstract available


  375. KRASENBAUM LJ
    A Review of "Hormonal Contraceptives and Migraine With Aura - Is There Still a Risk?"
    Headache. 2017;57:313.
    PubMed    


  376. POWERS SW, Hershey AD, Coffey CS
    The Childhood and Adolescent Migraine Prevention (CHAMP) Study: "What Do We Do Now?"
    Headache. 2017;57:180-183.
    PubMed    


  377. BLUMENTHAL H
    An American Headache Doctor in Beijing.
    Headache. 2017;57:309-312.
    PubMed    


    January 2017
  378. SENG EK, Buse DC, Klepper JE, J Mayson S, et al
    Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center.
    Headache. 2017 Jan 31. doi: 10.1111/head.13021.
    PubMed     Abstract available


  379. ORDAS CM, Torres-Gaona G, Pardo-Moreno J, Cuadrado ML, et al
    Case Report: Prolonged Dysphonia During Migraine Attacks.
    Headache. 2017 Jan 30. doi: 10.1111/head.13026.
    PubMed    


  380. ROBBINS NM, Bernat JL
    Minority Representation in Migraine Treatment Trials.
    Headache. 2017 Jan 27. doi: 10.1111/head.13018.
    PubMed     Abstract available


  381. GROSSMAN TB, Govindappagari S, Dayal AK, Robbins MS, et al
    Delivery Outcomes of Patients with Acute Migraine in Pregnancy: A Retrospective Study.
    Headache. 2017 Jan 18. doi: 10.1111/head.13023.
    PubMed     Abstract available


  382. TARANTINO S, De Ranieri C, Dionisi C, Gagliardi V, et al
    Role of the Attachment Style in Determining the Association Between Headache Features and Psychological Symptoms in Migraine Children and Adolescents. An Analytical Observational Case-Control Study.
    Headache. 2017 Jan 6. doi: 10.1111/head.13007.
    PubMed     Abstract available


    December 2016
  383. NG QX, Venkatanarayanan N, Kumar L
    A Systematic Review and Meta-Analysis of the Efficacy of Cognitive Behavioral Therapy for the Management of Pediatric Migraine.
    Headache. 2016 Dec 28. doi: 10.1111/head.13016.
    PubMed     Abstract available


  384. NEEB L, Bastian K, Villringer K, Israel H, et al
    Structural Gray Matter Alterations in Chronic Migraine: Implications for a Progressive Disease?
    Headache. 2016 Dec 28. doi: 10.1111/head.13012.
    PubMed     Abstract available


  385. BOND DS, Pavlovic JM, Lipton RB, Graham Thomas J, et al
    Sexual Dysfunction in Women With Migraine and Overweight/Obesity: Relative Frequency and Association With Migraine Severity.
    Headache. 2016 Dec 28. doi: 10.1111/head.13019.
    PubMed     Abstract available


  386. BARKER AT, Shields K
    Transcranial Magnetic Stimulation: Basic Principles and Clinical Applications in Migraine.
    Headache. 2016 Dec 28. doi: 10.1111/head.13002.
    PubMed     Abstract available


  387. CARVALHO GF, Bonato P, Florencio LL, Pinheiro CF, et al
    Balance Impairments in Different Subgroups of Patients With Migraine.
    Headache. 2016 Dec 19. doi: 10.1111/head.13009.
    PubMed     Abstract available


  388. FULLER-THOMSON E, Jayanthikumar J, Agbeyaka SK
    Untangling the Association Between Migraine, Pain, and Anxiety: Examining Migraine and Generalized Anxiety Disorders in a Canadian Population Based Study.
    Headache. 2016 Dec 19. doi: 10.1111/head.13010.
    PubMed     Abstract available


  389. TIETJEN GE, Karmakar M, Amialchuk AA
    Emotional Abuse History and Migraine Among Young Adults: A Retrospective Cross-Sectional Analysis of the Add Health Dataset.
    Headache. 2016 Dec 5. doi: 10.1111/head.12994.
    PubMed     Abstract available


  390. AURORA SK, Brin MF
    Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.
    Headache. 2016 Dec 2. doi: 10.1111/head.12999.
    PubMed     Abstract available


  391. KATO Y, Hayashi T, Kobayashi T, Masuoka A, et al
    De Novo Migraine With Aura After Surgical Repair of Aortic Coarctation.
    Headache. 2016 Dec 2. doi: 10.1111/head.12995.
    PubMed     Abstract available


  392. LIU IY, Ishiyama A, Sepahdari AR, Johnson K, et al
    Bilateral Endolymphatic Hydrops in a Patient With Migraine Variant Without Vertigo: A Case Report.
    Headache. 2016 Dec 2. doi: 10.1111/head.12976.
    PubMed     Abstract available


  393. MAASUMI K, Tepper SJ, Kriegler JS
    Menstrual Migraine and Treatment Options: Review.
    Headache. 2016 Dec 2. doi: 10.1111/head.12978.
    PubMed     Abstract available


    November 2016
  394. SILBERSTEIN SD
    Topiramate in Migraine Prevention: A 2016 Perspective.
    Headache. 2016 Nov 30. doi: 10.1111/head.12997.
    PubMed     Abstract available


  395. RHEE TG, Harris IM
    Gender Differences in the Use of Complementary and Alternative Medicine and Their Association With Moderate Mental Distress in U.S. Adults With Migraines/Severe Headaches.
    Headache. 2016 Nov 25. doi: 10.1111/head.12986.
    PubMed     Abstract available


  396. BARON J, Ruiz M, Palacios-Cena M, Madeleine P, et al
    Differences in Topographical Pressure Pain Sensitivity Maps of the Scalp Between Patients With Migraine and Healthy Controls.
    Headache. 2016 Nov 25. doi: 10.1111/head.12984.
    PubMed     Abstract available


  397. RAGGI A, Giovannetti AM, Leonardi M, Sansone E, et al
    Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study.
    Headache. 2016 Nov 14. doi: 10.1111/head.12979.
    PubMed     Abstract available


  398. BUSE DC, Reed ML, Fanning KM, Kurth T, et al
    Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Headache. 2016 Nov 12. doi: 10.1111/head.12962.
    PubMed     Abstract available


  399. TAGA A, Russo M, Manzoni GC, Torelli P, et al
    Cluster Headache With Accompanying Migraine-Like Features: A Possible Clinical Phenotype.
    Headache. 2016 Nov 10. doi: 10.1111/head.12971.
    PubMed     Abstract available


  400. FERREIRA KS, Guilherme G, Faria VR, Borges LM, et al
    Women Living Together Have a Higher Frequency of Menstrual Migraine.
    Headache. 2016 Nov 10. doi: 10.1111/head.12969.
    PubMed     Abstract available


  401. SHIRAHIGE L, Melo L, Nogueira F, Rocha S, et al
    Efficacy of Noninvasive Brain Stimulation on Pain Control in Migraine Patients: A Systematic Review and Meta-Analysis.
    Headache. 2016;56:1565-1596.
    PubMed     Abstract available


  402. MAINARDI F, Zanchin G, Maggioni F
    Olfactory Aura: A Missing Tool?
    Headache. 2016;56:1670.
    PubMed    


    October 2016
  403. KOWACS F, Ferreira Gomes M, Pigozzo T, Rodrigues Palmeira AL, et al
    Migraine-Like Headache as Presentation Symptom in Susac Syndrome.
    Headache. 2016 Oct 26. doi: 10.1111/head.12991.
    PubMed    


  404. FORNAZIERI MA, Neto AR, de Rezende Pinna F, Gobbi Porto FH, et al
    Olfactory symptoms reported by migraineurs with and without auras.
    Headache. 2016 Oct 25. doi: 10.1111/head.12973.
    PubMed     Abstract available


  405. CALHOUN AH
    Hormonal Contraceptives and Migraine With Aura-Is There Still a Risk?
    Headache. 2016 Oct 24. doi: 10.1111/head.12960.
    PubMed     Abstract available


  406. ABKUR TM, Omer E, Saeed M
    A case of stroke-like migraine attacks after radiation therapy.
    Headache. 2016 Oct 20. doi: 10.1111/head.12967.
    PubMed    


  407. LIPTON RB, Munjal S, Buse DC, Fanning KM, et al
    Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Headache. 2016 Oct 12. doi: 10.1111/head.12941.
    PubMed     Abstract available


  408. PATEL T, Elphick A, Jackson JE, Shovlin CL, et al
    Injections of Intravenous Contrast for Computerized Tomography Scans Precipitate Migraines in Hereditary Hemorrhagic Telangiectasia Subjects at Risk of Paradoxical Emboli: Implications for Right-to-Left Shunt Risks.
    Headache. 2016 Oct 11. doi: 10.1111/head.12963.
    PubMed     Abstract available


  409. SCHANKIN CJ, Viana M, Goadsby PJ
    Persistent and Repetitive Visual Disturbances in Migraine: A Review.
    Headache. 2016 Oct 7. doi: 10.1111/head.12946.
    PubMed     Abstract available


  410. CALHOUN AH, Gill N
    Presenting a New, Non-Hormonally Mediated Cyclic Headache in Women: End-Menstrual Migraine.
    Headache. 2016 Oct 5. doi: 10.1111/head.12942.
    PubMed     Abstract available


  411. JUSTUSSON E, Han DD, Kapoor S, Smith JH, et al
    Odorant-Triggered Migraine Attacks in a Case of Iatrogenic Olfactory Neuropathy.
    Headache. 2016;56:1512-1513.
    PubMed    


    September 2016
  412. SCHULTE LH, May A
    Functional Neuroimaging in Migraine: Chances and Challenges.
    Headache. 2016 Sep 22. doi: 10.1111/head.12944.
    PubMed     Abstract available


  413. CERNUDA-MOROLLON E, Riesco N, Martinez-Camblor P, Serrano-Pertierra E, et al
    No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
    Headache. 2016 Sep 16. doi: 10.1111/head.12949.
    PubMed     Abstract available


  414. DUSSOR G, Cao YQ
    TRPM8 and Migraine.
    Headache. 2016 Sep 16. doi: 10.1111/head.12948.
    PubMed     Abstract available


  415. VURALLI D, Evren Boran H, Cengiz B, Coskun O, et al
    Chronic Migraine Is Associated With Sustained Elevation of Somatosensory Temporal Discrimination Thresholds.
    Headache. 2016 Sep 16. doi: 10.1111/head.12947.
    PubMed     Abstract available


  416. LARROSA D, Ramon C, Alvarez R, Martinez-Camblor P, et al
    No Relationship Between Patent Foramen Ovale and Migraine Frequency.
    Headache. 2016 Sep 16. doi: 10.1111/head.12945.
    PubMed     Abstract available


  417. MUNJAL S, Gautam A, Offman E, Brand-Schieber E, et al
    A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Headache. 2016 Sep 10. doi: 10.1111/head.12905.
    PubMed     Abstract available


    June 2016
  418. KEMPNER J
    What Biology Can't Do.
    Headache. 2016;56:1047-52.
    PubMed    


  419. GIL-GOUVEIA R, Oliveira AG, Pavao Martins I
    Clinical Utility of the Mig-SCog.
    Headache. 2016;56:941-51.
    PubMed     Abstract available


    March 2016
  420. DONNET A, Braunstein D, Pradel V, Sciortino V, et al
    Ergot Use and Overuse: A Pharmacoepidemiology Retrospective Cohort Study.
    Headache. 2016;56:547-54.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: